Adoption of a pregnancy‐specific intravenous insulin protocol (Pregnancy‐IVI) at a regional centre has equivalent safety and efficacy outcomes as a tertiary hospital.

Autor:	Rowe, Christopher W., Qiao, Vivian, Ramesh, Soundarya, Rosee, Patrick, Sathiakumar, Angeline, McWhae‐Brown, Sienna, Griffiths, Eliza, Wynne, Katie
Předmět:	INSULIN therapy DRUG efficacy HOSPITALS INTRAVENOUS therapy CONFIDENCE intervals GLYCEMIC control BLOOD sugar monitoring TERTIARY care WOMEN RETROSPECTIVE studies BETAMETHASONE MANN Whitney U Test DESCRIPTIVE statistics GESTATIONAL diabetes PATIENT safety LONGITUDINAL method
Zdroj:	Diabetic Medicine; Jan2023, Vol. 40 Issue 1, p1-3, 3p
Abstrakt:	In the article, the authors present a retrospective cohort study which examined the real-world safety and efficacy data of the Pregnancy-IVI variable rate intravenous insulin (VRII) protocol in regional obstetric hospitals and tertiary-referral hospitals in Australia, particularly with respect to the risk of maternal hypoglycaemia in women with diabetes in pregnancy (DIP). Based on data, the protocol is safe and effective in both high-volume tertiary centres and lower volume centres.
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text